SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies

References

• Abbas, S., B. Abbas, S. Amir, and M. Wajahat. 2021. Evaluation of adverse effects with COVID-19 vaccination in Pakistan. Pakistan Journal of Medical Sciences 37 (7):1959–64. doi: 10.12669/pjms.37.7.4522.
   PubMed Web of Science ®Google Scholar
• Abbasinia, M., A. Hormati, S. K. E. Hossaini, S. Y. F. Ghomi, F. Zamani, M. Afifian, and S. Ahmadpour. 2021. Clinical manifestations of gastrointestinal symptoms in COVID-19 patients: An integrative review. Gastroenterology Nursing 44 (1):E1–E10. doi: 10.1097/SGA.0000000000000584.
   PubMed Web of Science ®Google Scholar
• Abt, M. C., L. C. Osborne, L. A. Monticelli, T. A. Doering, T. Alenghat, G. F. Sonnenberg, M. A. Paley, M. Antenus, K. L. Williams, J. Erikson, et al. 2012. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37 (1):158–70. doi: 10.1016/j.immuni.2012.04.011.
   PubMed Web of Science ®Google Scholar
• Ahlawat, S, and K. K. Sharma. 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Research 286 (198103):198103. doi: 10.1016/j.virusres.2020.198103.
   PubMedGoogle Scholar
• Alberca, G. G. F., R. L. Solis-Castro, M. E. Solis-Castro, and R. W. Alberca. 2021. Coronavirus disease–2019 and the intestinal tract: An overview. World Journal of Gastroenterology 27 (13):1255–66. doi: 10.3748/wjg.v27.i13.1255.
   PubMed Web of Science ®Google Scholar
• Ali, A. M., H. Kunugi, H. A. Abdelmageed, A. S. Mandour, M. E. Ahmed, S. Ahmad, and A. O. Hendawy. 2021. Vitamin K in COVID-19—potential anti-covid-19 properties of fermented milk fortified with bee honey as a natural source of vitamin K and probiotics. Fermentation 7 (4):202. doi: 10.3390/fermentation7040202.
   Google Scholar
• Anwar, F., H. N. Altayb, F. A. Al-Abbasi, A. L. Al-Malki, M. A. Kamal, and V. Kumar. 2021. Antiviral effects of probiotic metabolites on COVID-19. Journal of Biomolecular Structure & Dynamics 39 (11):4175–84. doi: 10.1080/07391102.2020.1775123.
   PubMed Web of Science ®Google Scholar
• Atarashi, K., T. Tanoue, K. Oshima, W. Suda, Y. Nagano, H. Nishikawa, S. Fukuda, T. Saito, S. Narushima, K. Hase, et al. 2013. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (7461):232–6. doi: 10.1038/nature12331.
   PubMed Web of Science ®Google Scholar
• Augusti, P. R., G. M. Conterato, C. C. Denardin, I. D. Prazeres, A. T. Serra, M. R. Bronze, and T. Emanuelli. 2021. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: Implications for COVID-19. The Journal of Nutritional Biochemistry 97:108787. doi: 10.1016/j.jnutbio.2021.108787.
   PubMed Web of Science ®Google Scholar
• Awadasseid, A., Y. Wu, Y. Tanaka, and W. Zhang. 2020. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. International Journal of Biological Sciences 16 (11):1846–60. doi: 10.7150/ijbs.45018.
   PubMed Web of Science ®Google Scholar
• Ayechu-Muruzabal, V., L. Xiao, T. Wehkamp, I. van Ark, E. J. Hoogendoorn, T. Leusink-Muis, G. Folkerts, J. Garssen, L. E. Willemsen, and B. Van’T Land. 2021. A fermented milk matrix containing postbiotics supports Th1-and Th17-type immunity In Vitro and modulates the influenza-specific vaccination response In Vivo in association with altered serum galectin ratios. Vaccines 9 (3):254. doi: 10.3390/vaccines9030254.
   Web of Science ®Google Scholar
• Azer, S. A. 2020. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes and New Infections 37:100738. doi: 10.1016/j.nmni.2020.100738.
   PubMed Web of Science ®Google Scholar
• Bevova, M., S. Netesov, and Y. S. Aulchenko. 2020. The new coronavirus COVID-19 infection. Molecular Genetics, Microbiology and Virology 35 (2):53–60. doi: 10.3103/S0891416820020044.
   PubMed Web of Science ®Google Scholar
• Beyerstedt, S., E. B. Casaro, and É. B. Rangel. 2021. COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. European Journal of Clinical Microbiology & Infectious Diseases 40 (5):905–19. doi: 10.1007/s10096-020-04138-6.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, R. P, and W. P. Hanage. 2022. Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant. The New England Journal of Medicine 386 (7):e14. doi: 10.1056/NEJMp2119682.
   PubMed Web of Science ®Google Scholar
• Bishehsari, F., D. Adnan, A. Deshmukh, S. R. Khan, T. Rempert, K. Dhana, and M. Mahdavinia. 2022. Gastrointestinal symptoms predict the outcomes from COVID-19 infection. Journal of Clinical Gastroenterology 56 (2):e145–e148. doi: 10.1097/MCG.0000000000001513.
   PubMed Web of Science ®Google Scholar
• Bonafè, M., F. Prattichizzo, A. Giuliani, G. Storci, J. Sabbatinelli, and F. Olivieri. 2020. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine & Growth Factor Reviews 53:33–7. doi: 10.1016/j.cytogfr.2020.04.005.
   PubMed Web of Science ®Google Scholar
• Bozkurt, H. S, and Ö. Bilen. 2021. Oral booster probiotic bifidobacteria in SARS-COV-2 patients. International Journal of Immunopathology and Pharmacology 35:20587384211059677. doi: 10.1177/20587384211059677.
   Web of Science ®Google Scholar
• Brawner, C. A., J. K. Ehrman, S. Bole, D. J. Kerrigan, S. S. Parikh, B. K. Lewis, R. M. Gindi, C. Keteyian, K. Abdul-Nour, and S. J. Keteyian. 2021. Inverse relationship of maximal exercise capacity to hospitalization secondary to coronavirus disease 2019. Mayo Clinic Proceedings 96 (1):32–9. doi: 10.1016/j.mayocp.2020.10.003.
   PubMed Web of Science ®Google Scholar
• Budden, K. F., S. L. Gellatly, D. L. Wood, M. A. Cooper, M. Morrison, P. Hugenholtz, and P. M. Hansbro. 2017. Emerging pathogenic links between microbiota and the gut–lung axis. Nature Reviews. Microbiology 15 (1):55–63. doi: 10.1038/nrmicro.2016.142.
   PubMed Web of Science ®Google Scholar
• Cai, R., C. Cheng, J. Chen, X. Xu, C. Ding, and B. Gu. 2020. Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon. Gut Microbes 11 (4):680–90. doi: 10.1080/19490976.2020.1735606.
   PubMed Web of Science ®Google Scholar
• Camargo, S. M., R. N. Vuille-dit-Bille, C. F. Meier, and F. Verrey. 2020. ACE2 and gut amino acid transport. Clinical Science 134 (21):2823–33. doi: 10.1042/CS20200477.
   Web of Science ®Google Scholar
• Ceccarelli, G., C. Borrazzo, C. Pinacchio, L. Santinelli, G. P. Innocenti, E. N. Cavallari, L. Celani, M. Marazzato, F. Alessandri, F. Ruberto, et al. 2021. Oral bacteriotherapy in patients with COVID-19: A retrospective cohort study. Frontiers in Nutrition 7:613928. doi: 10.3389/fnut.2020.613928.
   PubMed Web of Science ®Google Scholar
• Chen, X., M. Zheng, M. Huang, S. Xiao, F. Lin, S. Chen, and S. Chen. 2020. Muscovy duck reovirus infection disrupts the composition of intestinal microbiota in muscovy ducklings. Current Microbiology 77 (5):769–78. doi: 10.1007/s00284-019-01865-8.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Z. Zhou, and W. Min. 2018. Mitochondria, oxidative stress and innate immunity. Frontiers in Physiology 9:1487. doi: 10.3389/fphys.2018.01487.
   PubMed Web of Science ®Google Scholar
• Cheung, K. S., I. F. N. Hung, P. P. Y. Chan, K. C. Lung, E. Tso, R. Liu, Y. Y. Ng, M. Y. Chu, T. W. H. Chung, A. R. Tam, et al. 2020. ChanPPY. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 159 (1):81–95. doi: 10.1053/j.gastro.2020.03.065.
   PubMed Web of Science ®Google Scholar
• Chi, Y., Y. Ge, B. Wu, W. Zhang, T. Wu, T. Wen, J. Liu, X. Guo, C. Huang, Y. Jiao, et al. 2020. Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. The Journal of Infectious Diseases 222 (5):746–54. doi: 10.1093/infdis/jiaa363.
   PubMed Web of Science ®Google Scholar
• Commission, N. H. and N. A. o. T. C. Medicine. 2020. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7). Chinese Medical Journal 133 (09):1087–95.
   PubMedGoogle Scholar
• Costagliola, G., E. Spada, P. Comberiati, and D. G. Peroni. 2021. Could nutritional supplements act as therapeutic adjuvants in COVID-19? Italian Journal of Pediatrics 47 (1):32–5. doi: 10.1186/s13052-021-00990-0.
   PubMed Web of Science ®Google Scholar
• Cristofori, F., V. N. Dargenio, C. Dargenio, V. L. Miniello, M. Barone, and R. Francavilla. 2021. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body. Frontiers in Immunology 12:578386. doi: 10.3389/fimmu.2021.578386.
   PubMed Web of Science ®Google Scholar
• Cucinotta, D, and M. Vanelli. 2020. WHO declares COVID-19 a pandemic. Acta Bio Medica: Atenei Parmensis 91 (1):157–60.
   PubMedGoogle Scholar
• da Rosa Mesquita, R., L. C. Francelino Silva Junior, F. M. Santos Santana, T. Farias de Oliveira, R. Campos Alcântara, G. Monteiro Arnozo, E. Rodrigues da Silva Filho, A. G. Galdino Dos Santos, E. J. Oliveira da Cunha, S. H. Salgueiro de Aquino, et al. 2021. Clinical manifestations of COVID-19 in the general population: Systematic review. Wiener Klinische Wochenschrift 133 (7-8):377–82. doi: 10.1007/s00508-020-01760-4.
   PubMed Web of Science ®Google Scholar
• Dahiya, D. S., A. Kichloo, M. Albosta, S. Pagad, and F. Wani. 2020. Gastrointestinal implications in COVID-19. Journal of Investigative Medicine 68 (8):1397–401. doi: 10.1136/jim-2020-001559.
   PubMed Web of Science ®Google Scholar
• Dai, M., D. Liu, M. Liu, F. Zhou, G. Li, Z. Chen, Z. Zhang, H. You, M. Wu, Q. Zheng, et al. 2020. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discovery 10 (6):783–91. doi: 10.1158/2159-8290.CD-20-0422.
   PubMed Web of Science ®Google Scholar
• Dang, A. T, and B. J. Marsland. 2019. Microbes, metabolites, and the gut–lung axis. Mucosal Immunology 12 (4):843–50. doi: 10.1038/s41385-019-0160-6.
   PubMed Web of Science ®Google Scholar
• Davani-Davari, D., M. Negahdaripour, I. Karimzadeh, M. Seifan, M. Mohkam, S. J. Masoumi, A. Berenjian, and Y. Ghasemi. 2019. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 8 (3):92. doi: 10.3390/foods8030092.
   PubMed Web of Science ®Google Scholar
• Delgado-Roche, L, and F. Mesta. 2020. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Archives of Medical Research 51 (5):384–7. doi: 10.1016/j.arcmed.2020.04.019.
   PubMed Web of Science ®Google Scholar
• d’Ettorre, G., G. Ceccarelli, M. Marazzato, G. Campagna, C. Pinacchio, F. Alessandri, F. Ruberto, G. Rossi, L. Celani, C. Scagnolari, et al. 2020. Challenges in the management of SARS-CoV2 infection: The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Frontiers in Medicine 7:389. doi: 10.3389/fmed.2020.00389.
   PubMed Web of Science ®Google Scholar
• Di Tommaso, N., A. Gasbarrini, and F. R. Ponziani. 2021. Intestinal barrier in human health and disease. International Journal of Environmental Research and Public Health 18 (23):12836. doi: 10.3390/ijerph182312836.
   PubMed Web of Science ®Google Scholar
• Dickson, R. P., J. R. Erb-Downward, F. J. Martinez, and G. B. Huffnagle. 2016. The microbiome and the respiratory tract. Annual Review of Physiology 78:481–504. doi: 10.1146/annurev-physiol-021115-105238.
   PubMed Web of Science ®Google Scholar
• Din, A. U., M. Mazhar, M. Waseem, W. Ahmad, A. Bibi, A. Hassan, N. Ali, W. Gang, G. Qian, R. Ullah, et al. 2021. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 133:110947. doi: 10.1016/j.biopha.2020.110947.
   PubMed Web of Science ®Google Scholar
• Effenberger, M., F. Grabherr, L. Mayr, J. Schwaerzler, M. Nairz, M. Seifert, R. Hilbe, S. Seiwald, S. Scholl-Buergi, G. Fritsche, et al. 2020. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69 (8):1543–4. doi: 10.1136/gutjnl-2020-321388.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D. 2018. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab Journal of Gastroenterology 19 (2):56–64. doi: 10.1016/j.ajg.2018.03.002.
   PubMed Web of Science ®Google Scholar
• Faderl, M., M. Noti, N. Corazza, and C. Mueller. 2015. Keeping bugs in check: the mucus layer as a critical component in maintaining intestinal homeostasis. IUBMB Life 67 (4):275–85. doi: 10.1002/iub.1374.
   PubMed Web of Science ®Google Scholar
• Fan, Y, and O. Pedersen. 2021. Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology 19 (1):55–71. doi: 10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Feng, Y., Y. Wang, P. Wang, Y. Huang, and F. Wang. 2018. Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cellular Physiology and Biochemistry 49 (1):190–205. doi: 10.1159/000492853.
   PubMedGoogle Scholar
• Fodor, A., B. Tiperciuc, C. Login, O. H. Orasan, A. L. Lazar, C. Buchman, P. Hanghicel, A. Sitar-Taut, R. Suharoschi, R. Vulturar, et al. 2021. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19—mechanisms and therapeutic targets. Oxidative Medicine and Cellular Longevity 2021:8671713.
   PubMed Web of Science ®Google Scholar
• Gao, J., Y. Li, Y. Wan, T. Hu, L. Liu, S. Yang, Z. Gong, Q. Zeng, Y. Wei, W. Yang, et al. 2019. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Frontiers in Microbiology 10:477. doi: 10.3389/fmicb.2019.00477.
   PubMed Web of Science ®Google Scholar
• Gareau, M. G., P. M. Sherman, and W. A. Walker. 2010. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews. Gastroenterology & Hepatology 7 (9):503–14. doi: 10.1038/nrgastro.2010.117.
   PubMed Web of Science ®Google Scholar
• Gautier, T., D.-L. Gall, A. Sweidan, Z. Tamanai-Shacoori, A. Jolivet-Gougeon, O. Loréal, and L. Bousarghin. 2021. Next-generation probiotics and their metabolites in COVID-19. Microorganisms 9 (5):941. doi: 10.3390/microorganisms9050941.
   PubMed Web of Science ®Google Scholar
• Ghosh, S. S., J. Wang, P. J. Yannie, and S. Ghosh. 2020. Intestinal barrier dysfunction, LPS translocation, and disease development. Journal of the Endocrine Society 4 (2):bvz039. doi: 10.1210/jendso/bvz039.
   PubMed Web of Science ®Google Scholar
• Gjyshi, O., V. Bottero, M. V. Veettil, S. Dutta, V. V. Singh, L. Chikoti, and B. Chandran. 2014. Kaposi’s sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection. PLoS Pathogens 10 (10):e1004460. doi: 10.1371/journal.ppat.1004460.
   PubMed Web of Science ®Google Scholar
• Gobbi, M., A. Brunani, M. Arreghini, G. Baccalaro, D. Dellepiane, V. La Vela, E. Lucchetti, M. Barbaglia, A. Cova, E. Fornara, et al. 2021. Nutritional status in post SARS-Cov2 rehabilitation patients. Clinical Nutrition doi: 10.1016/j.clnu.2021.04.013.
   Google Scholar
• Gouda, A. S., F. G. Adbelruhman, H. S. Alenezi, and B. Mégarbane. 2021. Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients–A narrative review and hypotheses. Saudi Journal of Biological Sciences 28 (10):5897–905. doi: 10.1016/j.sjbs.2021.06.046.
   PubMed Web of Science ®Google Scholar
• Greco, S., N. Fabbri, A. Bella, B. Bonsi, S. Parini, C. Rocchi, S. Giaccari, M. Gavioli, A. Passaro, and C. V. Feo. 2021. COVID-19 inpatients with gastrointestinal onset: Sex and care needs’ differences in the district of Ferrara, Italy. BMC Infectious Diseases 21 (1):1–8. doi: 10.1186/s12879-021-06476-y.
   PubMed Web of Science ®Google Scholar
• Gu, S., Y. Chen, Z. Wu, Y. Chen, H. Gao, L. Lv, F. Guo, X. Zhang, R. Luo, C. Huang, et al. 2020. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clinical Infectious Diseases 71 (10):2669–78. doi: 10.1093/cid/ciaa709.
   PubMed Web of Science ®Google Scholar
• Guan, W.-J., Z.-Y. Ni, Y. Hu, W.-H. Liang, C.-Q. Ou, J.-X. He, L. Liu, H. Shan, C.-L. Lei, D. S. C. Hui, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 382 (18):1708–20. doi: 10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Guo, M., W. Tao, R. A. Flavell, and S. Zhu. 2021. Potential intestinal infection and faecal–oral transmission of SARS-CoV-2. Nature Reviews. Gastroenterology & Hepatology 18 (4):269–83. doi: 10.1038/s41575-021-00416-6.
   PubMed Web of Science ®Google Scholar
• Gupta, K. K., M. A. Khan, and S. K. Singh. 2020. Constitutive inflammatory cytokine storm: A major threat to human health. Journal of Interferon & Cytokine Research 40 (1):19–23. doi: 10.1089/jir.2019.0085.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Castrellón, P., T. Gandara-Martí, A. T. Abreu Y Abreu, C. D. Nieto-Rufino, E. López-Orduña, I. Jiménez-Escobar, C. Jiménez-Gutiérrez, G. López-Velazquez, and J. Espadaler-Mazo. 2022. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes 14 (1):2018899. doi: 10.1080/19490976.2021.2018899.
   PubMed Web of Science ®Google Scholar
• Hamming, I., W. Timens, M. Bulthuis, A. Lely, G. v Navis, and H. van Goor. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology 203 (2):631–7. doi: 10.1002/path.1570.
   PubMed Web of Science ®Google Scholar
• Han, C., C. Duan, S. Zhang, B. Spiegel, H. Shi, W. Wang, L. Zhang, R. Lin, J. Liu, Z. Ding, et al. 2020. Digestive symptoms in COVID-19 patients with mild disease severity: Clinical presentation, stool viral RNA testing, and outcomes. American Journal of Gastroenterology 115 (6):916–23. doi: 10.14309/ajg.0000000000000664.
   PubMed Web of Science ®Google Scholar
• Harris, E. V., J. C. de Roode, and N. M. Gerardo. 2019. Diet–microbiome–disease: Investigating diet’s influence on infectious disease resistance through alteration of the gut microbiome. PLoS Pathogens 15 (10):e1007891. doi: 10.1371/journal.ppat.1007891.
   PubMed Web of Science ®Google Scholar
• Hawryłkowicz, V., D. Lietz-Kijak, K. Kaźmierczak-Siedlecka, J. Sołek-Pastuszka, L. Stachowska, M. Folwarski, M. Parczewski, and E. Stachowska. 2021. Patient nutrition and probiotic therapy in COVID-19: what do we know in 2021? Nutrients 13 (10):3385. doi: 10.3390/nu13103385.
   PubMed Web of Science ®Google Scholar
• Hoel, H., L. Heggelund, D. H. Reikvam, B. Stiksrud, T. Ueland, A. E. Michelsen, K. Otterdal, K. E. Muller, A. Lind, F. Muller, et al. 2021. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. Journal of Internal Medicine 289 (4):523–31. doi: 10.1111/joim.13178.
   PubMed Web of Science ®Google Scholar
• Hu, B., S. Huang, and L. Yin. 2021. The cytokine storm and COVID-19. Journal of Medical Virology 93 (1):250–6. doi: 10.1002/jmv.26232.
   PubMed Web of Science ®Google Scholar
• Hu, J., L. Zhang, W. Lin, W. Tang, F. K. Chan, and S. C. Ng. 2021. Probiotics, prebiotics and dietary approaches during COVID-19 pandemic. Trends in Food Science & Technology 108:187–96. doi: 10.1016/j.tifs.2020.12.009.
   PubMed Web of Science ®Google Scholar
• Inan, M. S., R. J. Rasoulpour, L. Yin, A. K. Hubbard, D. W. Rosenberg, and C. Giardina. 2000. The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line. Gastroenterology 118 (4):724–34. doi: 10.1016/S0016-5085(00)70142-9.
   PubMed Web of Science ®Google Scholar
• Ivashkin, V., V. Fomin, S. Moiseev, M. Brovko, R. Maslennikov, A. Ulyanin, V. Sholomova, M. Vasilyeva, E. Trush, and O. Shifrin. 2021. Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the treatment of hospitalized patients with COVID-19: a randomized controlled trial. Probiotics and Antimicrobial Proteins 2021:1–9.
   Google Scholar
• Jin, X., J.-S. Lian, J.-H. Hu, J. Gao, L. Zheng, Y.-M. Zhang, S.-R. Hao, H.-Y. Jia, H. Cai, X.-L. Zhang, et al. 2020. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 69 (6):1002–9. doi: 10.1136/gutjnl-2020-320926.
   PubMed Web of Science ®Google Scholar
• Jin, B., R. Singh, S. E. Ha, H. Zogg, P. J. Park, and S. Ro. 2021. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World Journal of Gastroenterology 27 (19):2341–52. doi: 10.3748/wjg.v27.i19.2341.
   PubMed Web of Science ®Google Scholar
• Johansson, M. E. V., D. Ambort, T. Pelaseyed, A. Schütte, J. K. Gustafsson, A. Ermund, D. B. Subramani, J. M. Holmén-Larsson, K. A. Thomsson, J. H. Bergström, et al. 2011. Composition and functional role of the mucus layers in the intestine. Cellular and Molecular Life Sciences: CMLS 68 (22):3635–41. doi: 10.1007/s00018-011-0822-3.
   PubMed Web of Science ®Google Scholar
• Kageyama, Y., Y. Nishizaki, K. Aida, K. Yayama, T. Ebisui, T. Akiyama, and T. Nakamura. 2022. Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID‑19: a single‑arm, double‑blind, prospective trial combined with an in vitro cytokine response assay. Experimental and Therapeutic Medicine 23 (1):20–13. doi: 10.3892/etm.2021.10942.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh, K., S. A. Ward, K. Kalantar-Zadeh, and E. M. El-Omar. 2020. Considering the effects of microbiome and diet on SARS-CoV-2 infection: Nanotechnology roles. ACS Nano 14 (5):5179–82. doi: 10.1021/acsnano.0c03402.
   PubMed Web of Science ®Google Scholar
• Kasti, A. N., K. D. Synodinou, I. A. Pyrousis, M. D. Nikolaki, and K. D. Triantafyllou. 2021. Probiotics regulating inflammation via NLRP3 inflammasome modulation: a potential therapeutic approach for COVID-19. Microorganisms 9 (11):2376. doi: 10.3390/microorganisms9112376.
   PubMed Web of Science ®Google Scholar
• Kerry, R. G., J. K. Patra, S. Gouda, Y. Park, H.-S. Shin, and G. Das. 2018. Benefaction of probiotics for human health: a review. Journal of Food and Drug Analysis 26 (3):927–39. doi: 10.1016/j.jfda.2018.01.002.
   PubMed Web of Science ®Google Scholar
• Khatiwada, S, and A. Subedi. 2021. A mechanistic link between selenium and coronavirus disease 2019 (COVID-19). Current Nutrition Reports 10 (2):125–36. doi: 10.1007/s13668-021-00354-4.
   PubMedGoogle Scholar
• Kirtipal, N., S. Kumar, S. K. Dubey, V. D. Dwivedi, K. G. Babu, P. Malý, and S. Bharadwaj. 2022. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infection, Genetics and Evolution 99:105254. doi: 10.1016/j.meegid.2022.105254.
   PubMed Web of Science ®Google Scholar
• Klaunig, J. E. 2018. Oxidative stress and cancer. Current Pharmaceutical Design 24 (40):4771–8. doi: 10.2174/1381612825666190215121712.
   PubMed Web of Science ®Google Scholar
• König, J., J. Wells, P. D. Cani, C. L. García-Ródenas, T. MacDonald, A. Mercenier, J. Whyte, F. Troost, and R.-J. Brummer. 2016. Human intestinal barrier function in health and disease. Clinical and Translational Gastroenterology 7 (10):e196. doi: 10.1038/ctg.2016.54.
   PubMed Web of Science ®Google Scholar
• Lange, K. W. 2021. Food science and COVID-19. Food Science and Human Wellness 10 (1):1–5. doi: 10.1016/j.fshw.2020.08.005.
   Google Scholar
• Leal-Martínez, F., L. Abarca-Bernal, A. García-Pérez, D. González-Tolosa, G. Cruz-Cázares, M. Montell-García, and A. Ibarra. 2022. Effect of a nutritional support system to increase survival and reduce mortality in patients with COVID-19 in stage III and comorbidities: a blinded randomized controlled clinical trial. International Journal of Environmental Research and Public Health 19 (3):1172. doi: 10.3390/ijerph19031172.
   PubMed Web of Science ®Google Scholar
• Leaphart, C. L., and J. R. Tepas. 2007. The gut is a motor of organ system dysfunction. Surgery 141 (5):563–9. doi: 10.1016/j.surg.2007.01.021.
   PubMed Web of Science ®Google Scholar
• Lee, S. H., S. Fujioka, R. Takahashi, and T. Oe. 2019. Angiotensin II-induced oxidative stress in human endothelial cells: modification of cellular molecules through lipid peroxidation. Chemical Research in Toxicology 32 (7):1412–22. doi: 10.1021/acs.chemrestox.9b00110.
   PubMed Web of Science ®Google Scholar
• Lehmann, M., K. Allers, C. Heldt, J. Meinhardt, F. Schmidt, Y. Rodriguez-Sillke, D. Kunkel, M. Schumann, C. Böttcher, C. Stahl-Hennig, et al. 2021. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunology 14 (6):1381–92. doi: 10.1038/s41385-021-00437-z.
   PubMed Web of Science ®Google Scholar
• Lei, H.-Y., Y.-H. Ding, K. Nie, Y.-M. Dong, J.-H. Xu, M.-L. Yang, M.-Q. Liu, L. Wei, M. I. Nasser, L.-Y. Xu, et al. 2021. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 133:111064. doi: 10.1016/j.biopha.2020.111064.
   PubMed Web of Science ®Google Scholar
• Liang, W., Z. Feng, S. Rao, C. Xiao, X. Xue, Z. Lin, Q. Zhang, and W. Qi. 2020. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut 69 (6):1141–3. doi: 10.1136/gutjnl-2020-320832.
   PubMed Web of Science ®Google Scholar
• Li, Q., F. Cheng, Q. Xu, Y. Su, X. Cai, F. Zeng, and Y. Zhang. 2021. The role of probiotics in coronavirus disease-19 infection in Wuhan: a retrospective study of 311 severe patients. International Immunopharmacology 95:107531. doi: 10.1016/j.intimp.2021.107531.
   PubMed Web of Science ®Google Scholar
• Liguori, I., G. Russo, F. Curcio, G. Bulli, L. Aran, D. Della-Morte, G. Gargiulo, G. Testa, F. Cacciatore, D. Bonaduce, et al. 2018. Oxidative stress, aging, and diseases. Clinical Interventions in Aging 13:757–72. doi: 10.2147/CIA.S158513.
   PubMed Web of Science ®Google Scholar
• Li, L. q., T. Huang, Y. q Wang, Z. p Wang, Y. Liang, T. b Huang, H. y Zhang, W. Sun, and Y. Wang. 2020. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. Journal of Medical Virology 92 (6):577–83. doi: 10.1002/jmv.25757.
   PubMed Web of Science ®Google Scholar
• Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (6965):450–4. doi: 10.1038/nature02145.
   PubMed Web of Science ®Google Scholar
• Lin, L., X. Jiang, Z. Zhang, S. Huang, Z. Zhang, Z. Fang, Z. Gu, L. Gao, H. Shi, L. Mai, et al. 2020. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69 (6):997–1001. doi: 10.1136/gutjnl-2020-321013.
   PubMed Web of Science ®Google Scholar
• Liu, Y., A. H. Sawalha, and Q. Lu. 2021. COVID-19 and autoimmune diseases. Current Opinion in Rheumatology 33 (2):155–62. doi: 10.1097/BOR.0000000000000776.
   PubMed Web of Science ®Google Scholar
• Liu, P., Y. Wang, G. Yang, Q. Zhang, L. Meng, Y. Xin, and X. Jiang. 2021. The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacological Research 165:105420. doi: 10.1016/j.phrs.2021.105420.
   PubMed Web of Science ®Google Scholar
• Livanos, A. E., D. Jha, F. Cossarini, A. S. Gonzalez-Reiche, M. Tokuyama, T. Aydillo, T. L. Parigi, M. S. Ladinsky, I. Ramos, K. Dunleavy, et al. 2021. Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology 160 (7):2435–50. doi: 10.1053/j.gastro.2021.02.056.
   PubMed Web of Science ®Google Scholar
• Li, Z., K. Wang, X. Ji, H. Wang, and Y. Zhang. 2022. ACE2 suppresses the inflammatory response in LPS-induced porcine intestinal epithelial cells via regulating the NF-κB and MAPK pathways. Peptides 149:170717. doi: 10.1016/j.peptides.2021.170717.
   PubMed Web of Science ®Google Scholar
• Li, J., J. Zhao, X. Wang, A. Qayum, M. A. Hussain, G. Liang, J. Hou, Z. Jiang, and A. Li. 2019. Novel angiotensin-converting enzyme-inhibitory peptides from fermented bovine milk started by Lactobacillus helveticus KLDS. 31 and Lactobacillus casei KLDS. 105: Purification, identification, and interaction mechanisms. Frontiers in Microbiology 10:2643. doi: 10.3389/fmicb.2019.02643.
   PubMed Web of Science ®Google Scholar
• Lotfi, M., M. R. Hamblin, and N. Rezaei. 2020. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta; International Journal of Clinical Chemistry 508:254–66. doi: 10.1016/j.cca.2020.05.044.
   PubMed Web of Science ®Google Scholar
• Lu, L., H. Zhang, M. Zhan, J. Jiang, H. Yin, D. J. Dauphars, S.-Y. Li, Y. Li, and Y.-W. He. 2020. Preventing mortality in COVID-19 patients: Which cytokine to target in a raging storm? Frontiers in Cell and Developmental Biology 8:677. doi: 10.3389/fcell.2020.00677.
   PubMed Web of Science ®Google Scholar
• Lv, L., H. Jiang, Y. Chen, S. Gu, J. Xia, H. Zhang, Y. Lu, R. Yan, and L. Li. 2021. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Analytica Chimica Acta 1152:338267. doi: 10.1016/j.aca.2021.338267.
   PubMed Web of Science ®Google Scholar
• Maghool, F., A. Valiani, T. Safari, M. H. Emami, and S. Mohammadzadeh. 2021. Gastrointestinal and renal complications in SARS-CoV-2-infected patients: role of immune system. Scandinavian Journal of Immunology 93 (4):e12999. doi: 10.1111/sji.12999.
   PubMed Web of Science ®Google Scholar
• Mahooti, M., E. Abdolalipour, A. Salehzadeh, S. R. Mohebbi, A. Gorji, and A. Ghaemi. 2019. Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice. World Journal of Microbiology and Biotechnology 35 (6):1–9. doi: 10.1007/s11274-019-2667-0.
   Web of Science ®Google Scholar
• Mak, J. W., F. K. Chan, and S. C. Ng. 2020. Probiotics and COVID-19: one size does not fit all. The Lancet Gastroenterology & Hepatology 5 (7):644–5. doi: 10.1016/S2468-1253(20)30122-9.
   PubMed Web of Science ®Google Scholar
• Malagón-Rojas, J. N., A. Mantziari, S. Salminen, and H. Szajewska. 2020. Postbiotics for preventing and treating common infectious diseases in children: a systematic review. Nutrients 12 (2):389. doi: 10.3390/nu12020389.
   PubMed Web of Science ®Google Scholar
• Mancini, A., F. Campagna, P. Amodio, and K. M. Tuohy. 2018. Gut: liver: brain axis: the microbial challenge in the hepatic encephalopathy. Food & Function 9 (3):1373–88. doi: 10.1039/c7fo01528c.
   PubMed Web of Science ®Google Scholar
• Manna, S., T. Chowdhury, R. Chakraborty, and S. M. Mandal. 2021. Probiotics-derived peptides and their immunomodulatory molecules can play a preventive role against viral diseases including COVID-19. Probiotics and Antimicrobial Proteins 13 (3):611–23. doi: 10.1007/s12602-020-09727-7.
   PubMed Web of Science ®Google Scholar
• Marjot, T., G. Buescher, M. Sebode, E. Barnes, A. S. Barritt, M. J. Armstrong, L. Baldelli, J. Kennedy, C. Mercer, A.-K. Ozga, et al. 2021. SARS-CoV-2 infection in patients with autoimmune hepatitis. Journal of Hepatology 74 (6):1335–43. doi: 10.1016/j.jhep.2021.01.021.
   PubMed Web of Science ®Google Scholar
• Mohseni, A. H., V. Casolaro, L. G. Bermúdez-Humarán, H. Keyvani, and S. Taghinezhad-S. 2021. Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response. Gut Microbes 13 (1):1886844. doi: 10.1080/19490976.2021.1886844.
   PubMed Web of Science ®Google Scholar
• Mokarram, P., M. M. Dalivand, A. Pizuorno, F. Aligolighasemabadi, M. Sadeghdoust, E. Sadeghdoust, F. Aduli, G. Oskrochi, H. Brim, and H. Ashktorab. 2021. Clinical characteristics, gastrointestinal manifestations and outcomes of COVID-19 patients in Iran; does the location matters? World Journal of Clinical Cases 9 (18):4654–67. doi: 10.12998/wjcc.v9.i18.4654.
   PubMed Web of Science ®Google Scholar
• Mönkemüller, K., L. Fry, and S. Rickes. 2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel. Revista Espanola De Enfermedades Digestivas 112 (5):383–8.
   PubMed Web of Science ®Google Scholar
• Mucino-Bermejo, M. J. 2021. COVID-19 and the gastrointestinal tract. Gastroenterology Insights 12 (4):394–404. doi: 10.3390/gastroent12040038.
   Web of Science ®Google Scholar
• Muhammad, Y., Y. A. Kani, S. Iliya, J. B. Muhammad, A. Binji, A. El-Fulaty Ahmad, M. B. Kabir, K. Umar Bindawa, and A. U. Ahmed. 2021. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Medicine 9:205031212199124–8. doi: 10.1177/2050312121991246.
   Web of Science ®Google Scholar
• Nazir, Y., S. A. Hussain, A. Abdul Hamid, and Y. Song. 2018. Probiotics and their potential preventive and therapeutic role for cancer, high serum cholesterol, and allergic and HIV diseases. BioMed Research International 2018:3428437.
   PubMed Web of Science ®Google Scholar
• Oudit, G. Y., Z. Kassiri, M. P. Patel, M. Chappell, J. Butany, P. H. Backx, R. G. Tsushima, J. W. Scholey, R. Khokha, and J. M. Penninger. 2007. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovascular Research 75 (1):29–39. doi: 10.1016/j.cardiores.2007.04.007.
   PubMed Web of Science ®Google Scholar
• Oyagbemi, A. A., T. O. Ajibade, Y. G. Aboua, I. T. Gbadamosi, A. D. A. Adedapo, A. O. Aro, O. A. Adejumobi, E. Thamahane-Katengua, T. O. Omobowale, O. O. Falayi, et al. 2021. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic. Journal of Food Biochemistry 45 (2):e13604. doi: 10.1111/jfbc.13604.
   PubMed Web of Science ®Google Scholar
• Pan, L., M. Mu, P. Yang, Y. Sun, R. Wang, J. Yan, P. Li, B. Hu, J. Wang, C. Hu, et al. 2020. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American Journal of Gastroenterology 115 (5):766–73. doi: 10.14309/ajg.0000000000000620.
   PubMed Web of Science ®Google Scholar
• Paparo, L., C. Bruno, V. Ferrucci, E. Punto, M. Viscardi, G. Fusco, P. Cerino, A. Romano, M. Zollo, and R. B. Canani. 2021. Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes. Journal of Functional Foods 87:104787. doi: 10.1016/j.jff.2021.104787.
   PubMed Web of Science ®Google Scholar
• Park, M.-K., V. Ngo, Y.-M. Kwon, Y.-T. Lee, S. Yoo, Y.-H. Cho, S.-M. Hong, H. S. Hwang, E.-J. Ko, Y.-J. Jung, et al. 2013. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS One 8 (10):e75368. doi: 10.1371/journal.pone.0075368.
   PubMed Web of Science ®Google Scholar
• Penninger, J. M., M. B. Grant, and J. J. Sung. 2021. The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology 160 (1):39–46. doi: 10.1053/j.gastro.2020.07.067.
   PubMed Web of Science ®Google Scholar
• Peron, J. P. S, and H. Nakaya. 2020. Susceptibility of the elderly to SARS-CoV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE). Clinics 75:e1912. doi: 10.6061/clinics/2020/e1912.
   PubMed Web of Science ®Google Scholar
• Pincemail, J., E. Cavalier, C. Charlier, J.-P. Cheramy–Bien, E. Brevers, A. Courtois, M. Fadeur, S. Meziane, C. L. Goff, B. Misset, et al. 2021. Oxidative stress status in COVID-19 patients hospitalized in intensive care unit for severe pneumonia. A pilot study. Antioxidants 10 (2):257. doi: 10.3390/antiox10020257.
   Web of Science ®Google Scholar
• Portincasa, P., L. Bonfrate, M. Khalil, M. D. Angelis, F. M. Calabrese, M. D’amato, D. Q.-H. Wang, and A. Di Ciaula. 2021. Intestinal barrier and permeability in health, obesity and NAFLD. Biomedicines 10 (1):83. doi: 10.3390/biomedicines10010083.
   PubMed Web of Science ®Google Scholar
• Prasad, R., M. J. Patton, J. L. Floyd, C. P. Vieira, S. Fortmann, M. DuPont, A. Harbour, C. S. Jeremy, J. Wright, and R. Lamendella. 2021. Plasma microbiome in COVID-19 subjects: An indicator of gut barrier defects and dysbiosis. Biorxiv.
   Google Scholar
• Raman, B., M. P. Cassar, E. M. Tunnicliffe, N. Filippini, L. Griffanti, F. Alfaro-Almagro, T. Okell, F. Sheerin, C. Xie, M. Mahmod, et al. 2021. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 31:100683. doi: 10.1016/j.eclinm.2020.100683.
   PubMedGoogle Scholar
• Rather, I. A., S.-B. Choi, M. R. Kamli, K. R. Hakeem, J. S. Sabir, Y.-H. Park, and Y.-Y. Hor. 2021. Potential adjuvant therapeutic effect of Lactobacillus plantarum Probio-88 postbiotics against SARS-COV-2. Vaccines 9 (10):1067. doi: 10.3390/vaccines9101067.
   PubMed Web of Science ®Google Scholar
• Redd, W. D., J. C. Zhou, K. E. Hathorn, T. R. McCarty, A. N. Bazarbashi, C. C. Thompson, L. Shen, and W. W. Chan. 2020. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology 159 (2):765–7. e762. doi: 10.1053/j.gastro.2020.04.045.
   PubMed Web of Science ®Google Scholar
• Ren, Z., H. Wang, G. Cui, H. Lu, L. Wang, H. Luo, X. Chen, H. Ren, R. Sun, W. Liu, et al. 2021. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70 (7):1253–65. doi: 10.1136/gutjnl-2020-323826.
   PubMed Web of Science ®Google Scholar
• Rhodes, J., F. Dunstan, E. Laird, S. Subramanian, and R. A. Kenny. 2020. COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D. BMJ Nutrition, Prevention & Health 3 (1):118–20. doi: 10.1136/bmjnph-2020-000110.
   PubMedGoogle Scholar
• Rodrigues Prestes, T. R., N. P. Rocha, A. S. Miranda, A. L. Teixeira, and A. C. Simoes-e-Silva. 2017. The anti-inflammatory potential of ACE2/angiotensin-(1-7)/Mas receptor axis: evidence from basic and clinical research. Current Drug Targets 18 (11):1301–13. doi: 10.2174/1389450117666160727142401.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Leyva, D, and G. N. Pierce. 2021. The impact of nutrition on the COVID-19 pandemic and the impact of the COVID-19 pandemic on nutrition. Nutrients 13 (6):1752. doi: 10.3390/nu13061752.
   PubMed Web of Science ®Google Scholar
• Ruan, Q., K. Yang, W. Wang, L. Jiang, and J. Song. 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine 46 (5):846–8. doi: 10.1007/s00134-020-05991-x.
   PubMed Web of Science ®Google Scholar
• Salminen, S., M. C. Collado, A. Endo, C. Hill, S. Lebeer, E. M. M. Quigley, M. E. Sanders, R. Shamir, J. R. Swann, H. Szajewska, et al. 2021. The international scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews. Gastroenterology & Hepatology 18 (9):649–67. doi: 10.1038/s41575-021-00440-6.
   PubMed Web of Science ®Google Scholar
• Santacroce, L., F. Inchingolo, S. Topi, R. Del Prete, M. D. Cosola, I. A. Charitos, and M. Montagnani. 2021. Potential beneficial role of probiotics on the outcome of COVID-19 patients: an evolving perspective. Diabetes & Metabolic Syndrome 15 (1):295–301. doi: 10.1016/j.dsx.2020.12.040.
   PubMed Web of Science ®Google Scholar
• Scarpellini, E., L. M. Balsiger, V. Maurizi, E. Rinninella, A. Gasbarrini, N. Giostra, P. Santori, L. Abenavoli, and C. Rasetti. 2022. Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion. BioFactors (Oxford, England) 48 (2):294–306. doi: 10.1002/biof.1829.
   PubMed Web of Science ®Google Scholar
• Schmulson, M., U. C. Ghoshal, and G. Barbara. 2021. Managing the inevitable surge of post–COVID-19 functional gastrointestinal disorders. The American Journal of Gastroenterology 116 (1):4–7. doi: 10.14309/ajg.0000000000001062.
   PubMed Web of Science ®Google Scholar
• Shahramian, I., G. Kalvandi, H. Javaherizadeh, M. Khalili, N. M. Noori, M. Delaramnasab, and A. Bazi. 2018. The effects of prebiotic supplementation on weight gain, diarrhoea, constipation, fever and respiratory tract infections in the first year of life. Journal of Paediatrics and Child Health 54 (8):875–80. doi: 10.1111/jpc.13906.
   PubMed Web of Science ®Google Scholar
• Shang, J., G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach, and F. Li. 2020. Structural basis of receptor recognition by SARS-CoV-2. Nature 581 (7807):221–4. doi: 10.1038/s41586-020-2179-y.
   PubMed Web of Science ®Google Scholar
• Shao, H., D. Lan, Z. Duan, Z. Liu, J. Min, L. Zhang, J. Huang, J. Su, S. Chen, and A. Xu. 2006. Upregulation of mitochondrial gene expression in PBMC from convalescent SARS patients. Journal of Clinical Immunology 26 (6):546–54. doi: 10.1007/s10875-006-9046-y.
   PubMed Web of Science ®Google Scholar
• Shen, Z., Y. Xiao, L. Kang, W. Ma, L. Shi, L. Zhang, Z. Zhou, J. Yang, J. Zhong, D. Yang, et al. 2020. Genomic diversity of severe acute respiratory syndrome–coronavirus 2 in patients with coronavirus disease 2019. Clinical Infectious Diseases 71 (15):713–20. doi: 10.1093/cid/ciaa203.
   PubMed Web of Science ®Google Scholar
• Sies, H., V. V. Belousov, N. S. Chandel, M. J. Davies, D. P. Jones, G. E. Mann, M. P. Murphy, M. Yamamoto, and C. Winterbourn. 2022. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nature Reviews Molecular Cell Biology 23 (7):499–515. doi: 10.1038/s41580-022-00456-z.
   PubMed Web of Science ®Google Scholar
• Soltani, S., A. Zakeri, M. Zandi, M. M. Kesheh, A. Tabibzadeh, M. Dastranj, S. Faramarzi, M. Didehdar, H. Hafezi, P. Hosseini, et al. 2021. The role of bacterial and fungal human respiratory microbiota in COVID-19 patients. BioMed Research International 2021:1–13. doi: 10.1155/2021/6670798.
   PubMed Web of Science ®Google Scholar
• Song, P., W. Li, J. Xie, Y. Hou, and C. You. 2020. Cytokine storm induced by SARS-CoV-2. Clinica Chimica Acta; International Journal of Clinical Chemistry 509:280–7. doi: 10.1016/j.cca.2020.06.017.
   PubMed Web of Science ®Google Scholar
• Suárez-Fariñas, M., M. Tokuyama, G. Wei, R. Huang, A. Livanos, D. Jha, A. Levescot, H. Irizar, R. Kosoy, S. Cording, et al. 2021. Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2–related disease. Gastroenterology 160 (1):287–301. doi: 10.1053/j.gastro.2020.09.029.
   PubMed Web of Science ®Google Scholar
• Suhail, S., J. Zajac, C. Fossum, H. Lowater, C. McCracken, N. Severson, B. Laatsch, A. Narkiewicz-Jodko, B. Johnson, J. Liebau, et al. 2020. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. The Protein Journal 39 (6):644–56. doi: 10.1007/s10930-020-09935-8.
   PubMed Web of Science ®Google Scholar
• Sundararaman, A., M. Ray, P. Ravindra, and P. M. Halami. 2020. Role of probiotics to combat viral infections with emphasis on COVID-19. Applied Microbiology and Biotechnology 104 (19):8089–104. doi: 10.1007/s00253-020-10832-4.
   PubMed Web of Science ®Google Scholar
• Sun, Z., Z.-G. Song, C. Liu, S. Tan, S. Lin, J. Zhu, F.-H. Dai, J. Gao, J.-L. She, Z. Mei, et al. 2022. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Medicine 20 (1):1–13. doi: 10.1186/s12916-021-02212-0.
   PubMed Web of Science ®Google Scholar
• Sun, L. L., J. Wang, Y. S. Wang, P. F. Hu, Z. Q. Zhao, W. Chen, B. F. Ning, C. Yin, Y. S. Hao, Q. Wang, et al. 2021. Symptomatic features and prognosis of 932 hospitalized patients with coronavirus disease 2019 in Wuhan. Journal of Digestive Diseases 22 (5):271–81. doi: 10.1111/1751-2980.12983.
   PubMed Web of Science ®Google Scholar
• Tao, W., G. Zhang, X. Wang, M. Guo, W. Zeng, Z. Xu, D. Cao, A. Pan, Y. Wang, K. Zhang, et al. 2020. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Medicine in Microecology 5:100023. doi: 10.1016/j.medmic.2020.100023.
   PubMedGoogle Scholar
• Tawfick, M. M., H. Xie, C. Zhao, P. Shao, and M. A. Farag. 2022. Inulin fructans in diet: Role in gut homeostasis, immunity, health outcomes and potential therapeutics. International Journal of Biological Macromolecules 208:948–61. doi: 10.1016/j.ijbiomac.2022.03.218.
   PubMed Web of Science ®Google Scholar
• Tay, M. Z., C. M. Poh, L. Rénia, P. A. MacAry, and L. F. Ng. 2020. The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews. Immunology 20 (6):363–74. doi: 10.1038/s41577-020-0311-8.
   PubMed Web of Science ®Google Scholar
• Taziki Balajelini, M. H., A. Rajabi, M. Mohammadi, H. R. Nikoo, A. Tabarraei, M. Mansouri, and S. M. Hosseini. 2021. Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study. Clinical Otolaryngology 46 (6):1331–8. doi: 10.1111/coa.13844.
   PubMed Web of Science ®Google Scholar
• Thomas, R., J. Aldous, R. Forsyth, A. Chater, and M. Williams. 2021. The influence of a blend of probiotic lactobacillus and prebiotic inulin on the duration and severity of symptoms among individuals with COVID-19. Infectious Diseases Diagnosis & Treatment 5 (01):1–21. doi: 10.29011/2577-1515.100182.
   Google Scholar
• Tjan, L. H., K. Furukawa, T. Nagano, T. Kiriu, M. Nishimura, J. Arii, Y. Hino, S. Iwata, Y. Nishimura, and Y. Mori. 2021. Early differences in cytokine production distinguish severity of COVID-19. The Journal of Infectious Diseases 223 (7):1145–9. doi: 10.1093/infdis/jiab005.
   PubMed Web of Science ®Google Scholar
• Trompette, A., E. S. Gollwitzer, C. Pattaroni, I. C. Lopez-Mejia, E. Riva, J. Pernot, N. Ubags, L. Fajas, L. P. Nicod, and B. J. Marsland. 2018. Dietary fiber confers protection against flu by shaping Ly6c − patrolling monocyte hematopoiesis and CD8+ T cell metabolism. Immunity 48 (5):992–1005. doi: 10.1016/j.immuni.2018.04.022.
   PubMed Web of Science ®Google Scholar
• Trottein, F, and H. Sokol. 2020. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Reports 32 (3):107915. doi: 10.1016/j.celrep.2020.107915.
   PubMed Web of Science ®Google Scholar
• Tsai, Y.-L., T.-L. Lin, C.-J. Chang, T.-R. Wu, W.-F. Lai, C.-C. Lu, and H.-C. Lai. 2019. Probiotics, prebiotics and amelioration of diseases. Journal of Biomedical Science 26 (1):3–8. doi: 10.1186/s12929-018-0493-6.
   PubMedGoogle Scholar
• Tuddenham, S, and C. L. Sears. 2015. The intestinal microbiome and health. Current Opinion in Infectious Diseases 28 (5):464.
   PubMed Web of Science ®Google Scholar
• Vancamelbeke, M, and S. Vermeire. 2017. The intestinal barrier: A fundamental role in health and disease. Expert Review of Gastroenterology & Hepatology 11 (9):821–34. doi: 10.1080/17474124.2017.1343143.
   PubMed Web of Science ®Google Scholar
• Vecchié, A., A. Bonaventura, S. Toldo, L. Dagna, C. A. Dinarello, and A. Abbate. 2021. IL-18 and infections: Is there a role for targeted therapies? Journal of Cellular Physiology 236 (3):1638–57. doi: 10.1002/jcp.30008.
   PubMed Web of Science ®Google Scholar
• Venzon, M., L. Bernard-Raichon, J. Klein, J. Axelrad, G. Hussey, A. Sullivan, A. Casanovas-Massana, M. Noval, A. Valero-Jimenez, and J. Gago. 2021. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. bioRxiv 2022:35262080.
   Google Scholar
• Vodnar, D. C., L. Mitrea, B. E. Teleky, K. Szabo, L. F. Călinoiu, S. A. Nemeş, and G. A. Martău. 2020. Coronavirus disease (COVID-19) caused by (SARS-CoV-2) infections: A real challenge for human gut microbiota. Frontiers in Cellular and Infection Microbiology 10:575559. doi: 10.3389/fcimb.2020.575559.
   PubMed Web of Science ®Google Scholar
• Wang, D., B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, et al. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323 (11):1061–9. doi: 10.1001/jama.2020.1585.
   PubMed Web of Science ®Google Scholar
• Wang, J., H. Ji, S. Wang, H. Liu, W. Zhang, D. Zhang, and Y. Wang. 2018. Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota. Frontiers in Microbiology 9:1953.
   PubMed Web of Science ®Google Scholar
• Wang, Y., G. Wu, L. Zhao, and W. Wang. 2022. Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome. mBio 13 (2):e03801–03821. doi: 10.1128/mbio.03801-21.
   PubMed Web of Science ®Google Scholar
• Wang, Q., Y. Zhang, L. Wu, S. Niu, C. Song, Z. Zhang, G. Lu, C. Qiao, Y. Hu, K.-Y. Yuen, et al. 2020. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181 (4):894–904. doi: 10.1016/j.cell.2020.03.045.
   PubMed Web of Science ®Google Scholar
• Westfall, S., F. Carracci, M. Estill, D. Zhao, Q-l Wu, L. Shen, J. Simon, and G. M. Pasinetti. 2021. Optimization of probiotic therapeutics using machine learning in an artificial human gastrointestinal tract. Scientific Reports 11 (1):1–15. doi: 10.1038/s41598-020-79947-y.
   PubMed Web of Science ®Google Scholar
• Wu, J., J. Li, G. Zhu, Y. Zhang, Z. Bi, Y. Yu, B. Huang, S. Fu, Y. Tan, J. Sun, et al. 2020b. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clinical Journal of the American Society of Nephrology : CJASN 15 (8):1139–45. doi: 10.2215/CJN.04160320.
   PubMed Web of Science ®Google Scholar
• Wu, D., T. Wu, Q. Liu, and Z. Yang. 2020a. The SARS-CoV-2 outbreak: What we know. International Journal of Infectious Diseases: IJID 94:44–8. doi: 10.1016/j.ijid.2020.03.004.
   PubMed Web of Science ®Google Scholar
• Xiao, F., M. Tang, X. Zheng, Y. Liu, X. Li, and H. Shan. 2020. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158 (6):1831–3. doi: 10.1053/j.gastro.2020.02.055.
   PubMed Web of Science ®Google Scholar
• Xie, B., J. Zhang, Y. Li, S. Yuan, and Y. Shang. 2021. COVID-19: Imbalanced immune responses and potential immunotherapies. Frontiers in Immunology 11:607583. doi: 10.3389/fimmu.2020.607583.
   PubMed Web of Science ®Google Scholar
• Xu, L., C.-T. Ho, Y. Liu, Z. Wu, and X. Zhang. 2022. Potential application of tea polyphenols to the prevention of COVID-19 infection: based on the gut-lung axis. Frontiers in Nutrition 9:899842. doi: 10.3389/fnut.2022.899842.
   PubMed Web of Science ®Google Scholar
• Yang, Y., J. Huang, J. Li, H. Yang, and Y. Yin. 2020. The effects of butyric acid on the differentiation, proliferation, apoptosis, and autophagy of IPEC-J2 cells. Current Molecular Medicine 20 (4):307–17. doi: 10.2174/1566524019666191024110443.
   PubMed Web of Science ®Google Scholar
• Yang, T., E. M. Richards, C. J. Pepine, and M. K. Raizada. 2018. The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nature Reviews. Nephrology 14 (7):442–56. doi: 10.1038/s41581-018-0018-2.
   PubMed Web of Science ®Google Scholar
• Yang, W., Y. Tao, Y. Wu, X. Zhao, W. Ye, D. Zhao, L. Fu, C. Tian, J. Yang, F. He, et al. 2019. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair. Nature Communications 10 (1):1–14. doi: 10.1038/s41467-019-09046-8.
   PubMedGoogle Scholar
• Yang, X., Y. Yu, J. Xu, H. Shu, J. Xia, H. Liu, Y. Wu, L. Zhang, Z. Yu, M. Fang, et al. 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine 8 (5):475–81. doi: 10.1016/S2213-2600(20)30079-5.
   PubMed Web of Science ®Google Scholar
• Yaribeygi, H., T. Sathyapalan, S. L. Atkin, and A. Sahebkar. 2020. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxidative Medicine and Cellular Longevity 2020:1–13. doi: 10.1155/2020/8609213.
   Web of Science ®Google Scholar
• Ye, Q., B. Wang, and J. Mao. 2020. The pathogenesis and treatment of the Cytokine Storm’ in COVID-19. The Journal of Infection 80 (6):607–13. doi: 10.1016/j.jinf.2020.03.037.
   PubMed Web of Science ®Google Scholar
• Yeoh, Y. K., T. Zuo, G. C.-Y. Lui, F. Zhang, Q. Liu, A. Y. Li, A. C. Chung, C. P. Cheung, E. Y. Tso, K. S. Fung, et al. 2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70 (4):698–706. doi: 10.1136/gutjnl-2020-323020.
   PubMed Web of Science ®Google Scholar
• Zendeboodi, F., N. Khorshidian, A. M. Mortazavian, and A. G. da Cruz. 2020. Probiotic: conceptualization from a new approach. Current Opinion in Food Science 32:103–23. doi: 10.1016/j.cofs.2020.03.009.
   Web of Science ®Google Scholar
• Zhang, J., S. Garrett, and J. Sun. 2021a. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes & Diseases 8 (4):385–400. doi: 10.1016/j.gendis.2020.08.013.
   PubMed Web of Science ®Google Scholar
• Zhang, X.-F., X.-X. Guan, Y.-J. Tang, J.-F. Sun, X.-K. Wang, W.-D. Wang, and J.-M. Fan. 2021b. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: A systematic review and meta-analysis. European Journal of Nutrition 60 (5):2855–75. doi: 10.1007/s00394-021-02503-5.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Z. Kang, H. Gong, D. Xu, J. Wang, Z. Li, and H. Xu. 2020a. The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes. BioRxiv. doi: 10.1101/2020.01.30.927806.
   Google Scholar
• Zhang, H., J. M. Penninger, Y. Li, N. Zhong, and A. S. Slutsky. 2020b. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine 46 (4):586–90. doi: 10.1007/s00134-020-05985-9.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Z. Xu, J. W. Y. Mak, K. M. Chow, G. Lui, T. C. M. Li, C. K. Wong, P. K. S. Chan, J. Y. L. Ching, Y. Fujiwara, et al. 2022. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for. COVID-19: An open-label pilot study. Journal of Gastroenterology and Hepatology 37 (5):823–31. doi: 10.1111/jgh.15796.
   PubMed Web of Science ®Google Scholar
• Zhao, J. 2020. Investigating mechanism of Qing-Fei-Pai-Du-Tang for treatment of COVID-19 by network pharmacology. Chinese Traditional and Herbal Drugs 24:829–35.
   Google Scholar
• Zhao, Y., Y. Cao, S. Wang, K. Cai, and K. Xu. 2020. COVID-19 and gastrointestinal symptoms. The British Journal of Surgery 107 (10):e382–e383. doi: 10.1002/bjs.11821.
   PubMed Web of Science ®Google Scholar
• Zhou, T., J. Wu, Y. Zeng, J. Li, J. Yan, W. Meng, H. Han, F. Feng, J. He, S. Zhao, et al. 2022. SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. MedComm 3 (1):41–56. doi: 10.1002/mco2.112.
   Google Scholar
• Zhou, Z., N. Zhao, Y. Shu, S. Han, B. Chen, and X. Shu. 2020. Effect of gastrointestinal symptoms in patients with COVID-19. Gastroenterology 158 (8):2294–7. doi: 10.1053/j.gastro.2020.03.020.
   PubMed Web of Science ®Google Scholar
• Zorov, D. B., M. Juhaszova, and S. J. Sollott. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews 94 (3):909–50. doi: 10.1152/physrev.00026.2013.
   PubMed Web of Science ®Google Scholar
• Zuo, T., X. Wu, W. Wen, and P. Lan. 2021. Gut Microbiome Alterations in COVID-19. Genomics, Proteomics & Bioinformatics 19 (5):679–88. doi: 10.1016/j.gpb.2021.09.004.
   PubMed Web of Science ®Google Scholar
• Zuo, T., F. Zhang, G. C. Y. Lui, Y. K. Yeoh, A. Y. L. Li, H. Zhan, Y. Wan, A. C. K. Chung, C. P. Cheung, N. Chen, et al. 2020. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159 (3):944–55. doi: 10.1053/j.gastro.2020.05.048.
   PubMed Web of Science ®Google Scholar